InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-05-06 | Gilbert Cisneros(D-CA31) | house | Sale | $1,001 - $15,000 |
| 2024-10-31 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenues | $2.23B-6.3% | $2.38B+5.4% | $2.26B-0.9% | $2.28B+73.2% | $1.32B |
| Cost of Goods Sold | $1.41B-9.5% | $1.56B+2.5% | $1.52B-4.0% | $1.58B+91.8% | $824.8M |
| Gross profit | $822.0M-0.3% | $824.8M+11.5% | $739.9M+6.0% | $697.8M+42.0% | $491.5M |
| Selling, general and administrative | $625.2M-2.1% | $638.8M+5.3% | $606.7M-0.3% | $608.3M+101.1% | $302.6M |
| Research and development | $87.5M-1.3% | $88.6M+3.8% | $85.3M-8.2% | $93.0M+95.8% | $47.5M |
| Restructuring, strategic transaction and integration expenses | $66.5M+11.1% | $59.8M+45.0% | $41.3M-42.2% | $71.4M+296.0% | $18.0M |
| Change in fair value of contingent earn-out | $0+100.0% | -$5.4M+66.8% | -$16.2M+49.4% | -$32.1M | $0 |
| Total operating expenses | $779.2M-0.3% | $781.8M+9.0% | $717.0M-3.2% | $740.7M+101.1% | $368.2M |
| Income from operations | $42.8M-0.3% | $43.0M+88.2% | $22.8M+153.2% | -$42.9M-134.8% | $123.2M |
| Interest Expense, Net | -$83.0M+13.3% | -$95.8M-0.6% | -$95.2M-43.5% | -$66.4M | — |
| OTHER EXPENSE, NET | -$232K+98.2% | -$13.2M-123.9% | -$5.9M-15.0% | -$5.1M-151.6% | -$2.0M |
| Gain (Loss) on Disposition of Business | $44.8M | $0 | $0 | — | — |
| Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total | $4.4M+106.6% | -$66.0M+15.7% | -$78.3M | — | — |
| (Provision) benefit for income taxes | -$2.4M+95.3% | -$51.7M-206.2% | $48.6M+21.2% | $40.1M | — |
| Income (Loss) from Continuing Operations before Equity Method Investments | $1.9M+101.6% | -$117.7M-296.9% | -$29.7M | — | — |
| Income (Loss) from Equity Method Investments | -$1.2M | $0 | $0 | — | — |
| Net Income (Loss) | $732K+100.6% | -$117.7M-296.9% | -$29.7M | — | — |
| Basic | $30+100.6% | -$5K-292.7% | -$1K+60.5% | -$3K-164.0% | $5K |
| Diluted | $30+100.6% | -$5K-292.7% | -$1K+60.5% | -$3K-165.6% | $5K |
| Basic (in shares) | $24.6M+1.0% | $24.4M+1.2% | $24.1M+0.9% | $23.9M+12.6% | $21.2M |
| Diluted (in shares) | $24.9M+2.1% | $24.4M+1.2% | $24.1M+0.9% | $23.9M+9.6% | $21.8M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth
ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
ICU Medical Calls Itself a “Pure-Play Infusion” Leader, Details Pricing, Pumps and Buyback Plans